Sharpless Wonders Why Cancer Success Doesn't Translate To Other Diseases

 
• By Derrick Gingery
  
FDA acting Commissioner Ned Sharpless at Reagan-Udall Foundation for FDA. (1)
Acting FDA Commissioner Norman Sharpless wants the success in cancer drug development disseminated to other disease areas. • Source: File photo
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet